These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9716065)

  • 1. GMDP for psoriasis.
    Williamson D; Chawla M; Marks R
    Lancet; 1998 Aug; 352(9127):545. PubMed ID: 9716065
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune boosters. Murabutide--debut of a new immune booster?
    TreatmentUpdate; 2003; 15(4):3. PubMed ID: 17216851
    [No Abstract]   [Full Text] [Related]  

  • 3. GMDP and psoriasis.
    Bhushan M; McElhone K; Griffiths CE
    Lancet; 1998 Dec; 352(9143):1857. PubMed ID: 9851410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Theoretical problems of use of an immunomodulator likopid in clinical practice].
    Andronova TM; Chumakova MM
    Ter Arkh; 2002; 74(1):70-2. PubMed ID: 11878067
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antimetastatic effect of a liposome-enclosed analog of muramyl dipeptide].
    Umanskiĭ VIu; Stefanov AV; Bondar' OP; Balitskiĭ KP; Pinchuk VG
    Vopr Onkol; 1988; 34(4):433-8. PubMed ID: 2837005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
    Hornung RL; Longo DL; Gowda VL; Kwak LW
    Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulation of the nonspecific resistance by beta-heptylglycoside-muramyldipeptide in mice].
    Kaliuzhin OV; Kaliuzhin VV; Zemliakov AE; Elkina SI; Shkalev MV; Sergeev VV
    Biull Eksp Biol Med; 1999 May; 127(5):543-5. PubMed ID: 10399577
    [No Abstract]   [Full Text] [Related]  

  • 8. Muramylpeptides augment expression of Ia-antigens on mouse macrophages.
    Nesmeyanov VA; Khaidukov SV; Komaleva RL; Andronova TM; Ivanov VT
    Biomed Sci; 1990 Feb; 1(2):151-4. PubMed ID: 2102779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and prophylactic effects of romurtide against experimental animal infections.
    Niki Y; Tatara O
    Adv Exp Med Biol; 1992; 319():185-91. PubMed ID: 1414593
    [No Abstract]   [Full Text] [Related]  

  • 10. [Selective antiviral and immunomodulating therapy for herpetic keratitis].
    Maĭchuk IuF
    Klin Med (Mosk); 2001; 79(9):70-1. PubMed ID: 11641944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of likopid--an immunomodulator in the combined treatment of patients with endometrial adenocarcinoma].
    Venediktova MG; Rumiantseva NK; Fedorova GV; Demidova MA; Zhilenko MI
    Vopr Onkol; 2001; 47(4):481-4. PubMed ID: 11710296
    [No Abstract]   [Full Text] [Related]  

  • 12. Romurtide, a synthetic muramyl dipeptide derivative, accelerates peripheral platelet recovery in nonhuman primate chemotherapy model.
    Namba K; Nitanai H; Otani T; Azuma I
    Vaccine; 1996 Oct; 14(14):1322-6. PubMed ID: 9004440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion.
    Lyons KC; Charman WN; Miller R; Porter CJ
    Int J Pharm; 2000 Apr; 199(1):17-28. PubMed ID: 10794923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Litomosoides carinii in rodents: immunomodulation in potentiating action of diethylcarbamazine.
    Chatterjee RK; Fatma N; Jain RK; Gupta CM; Anand N
    Jpn J Exp Med; 1988 Dec; 58(6):243-8. PubMed ID: 3075985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP/GMDP formulated in nanoliposomes: stimulation of innate and adaptive immunity.
    Knotigová PT; Zyka D; Mašek J; Kovalová A; Křupka M; Bartheldyová E; Kulich P; Koudelka Š; Lukáč R; Kauerová Z; Vacek A; Horynová MS; Kozubík A; Miller AD; Fekete L; Kratochvílová I; Ježek J; Ledvina M; Raška M; Turánek J
    Pharm Res; 2015 Apr; 32(4):1186-99. PubMed ID: 25630814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of stromal herpetic keratitis with a new immunomodulator likopide].
    Maíchuk IF; Kazachenko MA; Shchipanova AI; Andzhelov VO; Krichevskaia GI
    Vestn Oftalmol; 1997; 113(4):23-6. PubMed ID: 9381637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and immunologic effect of likopid in complex therapy of occupational bronchial asthma].
    Tarasova OV
    Med Tr Prom Ekol; 2001; (11):31-4. PubMed ID: 11768952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Muramyl dipeptide derivatives in experimental and clinical use].
    Kaliuzhin OV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):104-8. PubMed ID: 9532704
    [No Abstract]   [Full Text] [Related]  

  • 19. Study on the reduction of chemotherapy induced neutropenia in mice using glucosaminylmuramyl dipeptide.
    Armstrong NA; Bolton EJ; Morris DL
    Arzneimittelforschung; 1999 Aug; 49(8):716-20. PubMed ID: 10483520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the cytokine inducer romurtide: experimental studies and clinical application.
    Azuma I
    Trends Pharmacol Sci; 1992 Dec; 13(12):425-8. PubMed ID: 1293866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.